Opioids, Sleep, and Sleep-Disordered Breathing

Author(s): Moshe Zutler, Jon-Erik C. Holty.

Journal Name: Current Pharmaceutical Design

Volume 17 , Issue 15 , 2011

Abstract:

Opioid medications are increasingly used to treat chronic pain. Opioid-associated respiratory depression, and their potential to cause nocturnal apneas, is increasingly recognized as a major contributor to nocturnal hypoxemia and sleep-disordered breathing. Given the widespread use of opioids, understanding their mechanism of action and their potential to cause adverse effects particularly during sleep is critical. This article reviews the salient features of the physiologic control of respiration and sleep, and the role opioids play in altering that regulation. Additionally, we summarize the evidence regarding the association between opioid use and sleep-disordered breathing and explore treatment modalities for opioid-associated nocturnal respiratory depression and apneas.

Keywords: Opioids, sleep-disordered breathing, sleep apnea, central sleep apnea, control of breathing, apnea, non-mailgnant, retrotrapezoid, escalation, synergistic, orphanin, hypoxia, hypercarbia, enkephalins, hydromorphone, methadone, narcotics, adenotonsillectomy, dexmedetomidine

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 15
Year: 2011
Page: [1443 - 1449]
Pages: 7
DOI: 10.2174/138161211796197070
Price: $58

Article Metrics

PDF: 16